Latest BML Capital Management, LLC Stock Portfolio
BML Capital Management, LLC Performance:
2025 Q4: 19.79%YTD: -8.75%2024: 9.79%
Performance for 2025 Q4 is 19.79%, and YTD is -8.75%, and 2024 is 9.79%.
About BML Capital Management, LLC and 13F Hedge Fund Stock Holdings
On 2026-02-03, the fund reported it's updated stock portfolio. In the 13F Holdings report, BML Capital Management, LLC reported an equity portfolio of $115.7 Millions as of 31 Dec, 2025.
The top stock holdings of BML Capital Management, LLC are ACRS, AVIR, ORMP. The fund has invested 37.1% of it's portfolio in ACLARIS THERAPEUTICS INC and 23.1% of portfolio in ATEA PHARMACEUTICALS INC.
The fund managers got completely rid off ADVERUM BIOTECHNOLOGIES INC (ADVM), ALUMIS INC and ATHIRA PHARMA INC (ATHA) stocks. They significantly reduced their stock positions in CONNECT BIOPHARMA HLDGS LTD, LISATA THERAPEUTICS INC (CLBS) and IMAGENEBIO INC (IKNA). BML Capital Management, LLC opened new stock positions in CARMAX INC (KMX), OUTSET MED INC (OM) and PLIANT THERAPEUTICS INC (PLRX). The fund showed a lot of confidence in some stocks as they added substantially to TARGET CORP (TGT) and ATEA PHARMACEUTICALS INC (AVIR).
The top stock holdings of BML Capital Management, LLC are ACRS, AVIR, ORMP. The fund has invested 37.1% of it's portfolio in ACLARIS THERAPEUTICS INC and 23.1% of portfolio in ATEA PHARMACEUTICALS INC.
The fund managers got completely rid off ADVERUM BIOTECHNOLOGIES INC (ADVM), ALUMIS INC and ATHIRA PHARMA INC (ATHA) stocks. They significantly reduced their stock positions in CONNECT BIOPHARMA HLDGS LTD, LISATA THERAPEUTICS INC (CLBS) and IMAGENEBIO INC (IKNA). BML Capital Management, LLC opened new stock positions in CARMAX INC (KMX), OUTSET MED INC (OM) and PLIANT THERAPEUTICS INC (PLRX). The fund showed a lot of confidence in some stocks as they added substantially to TARGET CORP (TGT) and ATEA PHARMACEUTICALS INC (AVIR).
BML Capital Management, LLC Annual Return Estimates Vs S&P 500
Our best estimate is that BML Capital Management, LLC made a return of 19.79% in the last quarter. In trailing 12 months, it's portfolio return was -8.75%.
- Performance
- S&P 500
New Buys
| Ticker | $ Bought |
|---|---|
| carmax inc | 5,989,200 |
| outset med inc | 2,015,200 |
| pliant therapeutics inc | 1,886,290 |
New stocks bought by BML Capital Management, LLC
Additions
| Ticker | % Inc. |
|---|---|
| target corp | 275 |
| atea pharmaceuticals inc | 0.21 |
Additions to existing portfolio by BML Capital Management, LLC
Reductions
| Ticker | % Reduced |
|---|---|
| connect biopharma hldgs ltd | -67.74 |
| lisata therapeutics inc | -33.22 |
| imagenebio inc | -3.00 |
BML Capital Management, LLC reduced stake in above stock
Sold off
| Ticker | $ Sold |
|---|---|
| third harmonic bio inc | 0.00 |
| adverum biotechnologies inc | -13,850,600 |
| lava therapeutics nv | -3,074,150 |
| alumis inc | -4,829,560 |
| athira pharma inc | -1,337,490 |
| astrotech corp | -1,080,010 |
| vistagen therapeutics inc | -532,500 |
| mural oncology pub ltd co | -119,025 |
BML Capital Management, LLC got rid off the above stocks
Sector Distribution
BML Capital Management, LLC has about 90.3% of it's holdings in Healthcare sector.
- Healthcare
- Consumer Cyclical
- Consumer Defensive
| Sector | % |
|---|---|
| Healthcare | 90.3 |
| Consumer Cyclical | 5.3 |
| Consumer Defensive | 3.2 |
Market Cap. Distribution
BML Capital Management, LLC has about 8.5% of it's portfolio invested in the large-cap and mega-cap stocks.
- MICRO-CAP
- LARGE-CAP
- NANO-CAP
- SMALL-CAP
| Category | % |
|---|---|
| MICRO-CAP | 84.6 |
| LARGE-CAP | 8.5 |
| NANO-CAP | 4.1 |
| SMALL-CAP | 1.7 |
Stocks belong to which Index?
About 84.5% of the stocks held by BML Capital Management, LLC either belong to S&P 500 or RUSSELL 2000 index.
- RUSSELL 2000
- Others
- S&P 500
| Index | % |
|---|---|
| RUSSELL 2000 | 76 |
| Others | 15.4 |
| S&P 500 | 8.5 |
BML Capital Management, LLC Holdings Map
This heatmap illustrates the top 50 positions within the fund's portfolio.
Current Stock Holdings of BML Capital Management, LLC
BML Capital Management, LLC has 13 stocks in it's portfolio. About 95.5% of the portfolio is in top 10 stocks. TIL proved to be the most loss making stock for the portfolio. ACRS was the most profitable stock for BML Capital Management, LLC last quarter.
Last Reported on: 03 Feb, 2026| Ticker | Namesorted ascending | % Portfolio | Shares Held | $ Value | Type | % Change | Options | |
|---|---|---|---|---|---|---|---|---|
| ACRS | aclaris therapeutics inc | 37.08 | 14,250,000 | 42,892,500 | unchanged | 0.00 | ||
| ADVM | adverum biotechnologies inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| ARVN | arvinas inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| ASTC | astrotech corp | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| ATHA | athira pharma inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| AVIR | atea pharmaceuticals inc | 23.11 | 7,490,000 | 26,739,300 | added | 0.21 | ||
| CLBS | lisata therapeutics inc | 0.12 | 73,348 | 136,427 | reduced | -33.22 | ||
| IKNA | imagenebio inc | 1.06 | 177,026 | 1,221,480 | reduced | -3.00 | ||
| KMX | carmax inc | 5.18 | 155,000 | 5,989,200 | new | |||
| KZR | kezar life sciences inc | 3.92 | 720,787 | 4,533,750 | unchanged | 0.00 | ||
| OM | outset med inc | 1.74 | 543,180 | 2,015,200 | new | |||
| ORMP | oramed pharmaceuticals inc | 7.80 | 3,167,230 | 9,026,610 | unchanged | 0.00 | ||
| PLRX | pliant therapeutics inc | 1.63 | 1,546,140 | 1,886,290 | new | |||
| PMVP | pmv pharmaceuticals inc | 5.72 | 5,292,000 | 6,615,000 | unchanged | 0.00 | ||
| TGT | target corp | 3.17 | 37,500 | 3,665,620 | added | 275 | ||
| THRD | third harmonic bio inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| TIL | instil bio inc | 6.14 | 645,600 | 7,101,600 | unchanged | 0.00 | ||
| VSTA | vistagen therapeutics inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| connect biopharma hldgs ltd | 1.00 | 408,887 | 1,153,060 | reduced | -67.74 | |||
| lava therapeutics nv | 0.00 | 0.00 | 0.00 | sold off | -100 | |||